Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
Gwen Schroyen, Jeroen Blommaert, Donatienne Van Weehaeghe, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4198-4198
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Cancer related cognitive impairment: a downside of cancer treatment
Kimberly Demos-Davies, Jessica Lawrence, Davis Seelig
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis
Zhuan Lv, Ruidong Liu, Kaiqi Su, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 32
Molecular mechanisms underlying cyclophosphamide-induced cognitive impairment and strategies for neuroprotection in preclinical models
Kamilia M. Ibrahim, Samar F. Darwish, Eman M. Mantawy, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1873-1893
Open Access | Times Cited: 18
Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
Senbang Yao, Qianqian Zhang, Xinxin Yao, et al.
Breast Cancer Research and Treatment (2023) Vol. 201, Iss. 1, pp. 15-26
Closed Access | Times Cited: 13
An overview of the relationship between inflammation and cognitive function in humans, molecular pathways and the impact of nutraceuticals
Chusana Mekhora, Daniel J. Lamport, Jeremy P.E. Spencer
Neurochemistry International (2024) Vol. 181, pp. 105900-105900
Open Access | Times Cited: 4
Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
Insilico and Invivo protective effect of biochanin-A mitigating doxorubicin- induced cognitive deficits and neuroinflammation: Insights to the role of p-Tau and miR-132
Sarah Hussein, Mai F. Tolba, Haidy E. Michel, et al.
NeuroToxicology (2025)
Closed Access
Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies
Ding Quan Ng, Daniella Chan, Parisa Agrawal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103748-103748
Open Access | Times Cited: 17
Cognitive impairment in adolescent and young adult cancer patients: Pre‐treatment findings of a longitudinal study
Alexandre Chan, Ivy Cheng, Claire Wang, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 4821-4831
Open Access | Times Cited: 17
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence
Margarita Kirienko, Paola Anna Erba, Arturo Chiti, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 1, pp. 107-124
Closed Access | Times Cited: 16
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe
Charlotte Sleurs, Ali Amidi, Lisa M. Wu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103859-103859
Open Access | Times Cited: 13
Cancer treatment induces neuroinflammation and behavioral deficits in mice
Kimberly Demos-Davies, Jessica Lawrence, Allison Rogich, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Longitudinal assessment of chemotherapy-induced brain connectivity changes in cerebral white matter and its correlation with cognitive functioning using the GQI
Vincent Chin‐Hung Chen, Wei Chuang, Yuan‐Hsiung Tsai, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Dietary EPA and DHA enrichment of a high fat diet during doxorubicin-based chemotherapy attenuated neuroinflammatory gene expression in the brain of C57bl/6 ovariectomized mice
Kate Ormiston, Z. Melink, Rebecca Andridge, et al.
Brain Behavior and Immunity (2024)
Closed Access | Times Cited: 2
Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges
Hannah R. Wardill, Luke T. Wooley, Olivia M. Bellas, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 19-30
Open Access | Times Cited: 6
Emerging roles of toll-like receptor 4 in chemotherapy-induced neurotoxicity
Thura Tun Oo, Wasana Pratchayasakul, Nipon Chattipakorn, et al.
NeuroToxicology (2022) Vol. 93, pp. 112-127
Closed Access | Times Cited: 10
A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue
Jan Petr, Louise Hogeboom, Pavel Nikulin, et al.
Magnetic Resonance Materials in Physics Biology and Medicine (2021) Vol. 35, Iss. 1, pp. 163-186
Open Access | Times Cited: 14
Cisplatin causes erectile dysfunction by decreasing endothelial and smooth muscle content and inducing cavernosal nerve senescence in rats
Yinghao Yin, Yihong Zhou, Jun Zhou, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5
The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models – A systematic review
Olivia J. Haller, Ines Semendric, Rebecca P. George, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105120-105120
Open Access | Times Cited: 5
Cognitive impairments associated with chemotherapy in women with breast cancer: a meta-analysis and meta-regression
Milena Edite Casé de Oliveira, G.S.V. Torres, Ramonyele Gomes Franklin, et al.
Brazilian Journal of Medical and Biological Research (2023) Vol. 56
Open Access | Times Cited: 5
Epirubicin Treatment Induces Neurobehavioral, Oxido-Inflammatory and Neurohistology Alterations in Rats: Protective Effect of the Endogenous Metabolite of Tryptophan − 3-Indolepropionic Acid
Solomon E. Owumi, Grace Adebisi
Neurochemical Research (2023) Vol. 48, Iss. 9, pp. 2767-2783
Closed Access | Times Cited: 4
The Impact of Mindfulness on Functional Brain Connectivity and Peripheral Inflammation in Breast Cancer Survivors with Cognitive Complaints
Michelle Melis, Gwen Schroyen, Jeroen Blommaert, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3632-3632
Open Access | Times Cited: 4
Longitudinal Neuropathological Consequences of Extracranial Radiation Therapy in Mice
Kimberly Demos-Davies, Jessica Lawrence, Jessica Coffey, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5731-5731
Open Access | Times Cited: 1
Neuroinflammation as potential precursor of leukoencephalopathy in early-stage breast cancer patients: A cross-sectional PET-MRI study
Gwen Schroyen, Charlotte Sleurs, Emilie Bartsoen, et al.
The Breast (2022) Vol. 62, pp. 61-68
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top